82 FR 12454 - Request for Nominations of Candidates To Serve on the Clinical Laboratory Improvement Advisory Committee (CLIAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 41 (March 3, 2017)

Page Range		12454-12455
FR Document		2017-04103

Federal Register, Volume 82 Issue 41 (Friday, March 3, 2017)

[Federal Register Volume 82, Number 41 (Friday, March 3, 2017)]
[Notices]
[Pages 12454-12455]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04103]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Request for Nominations of Candidates To Serve on the Clinical 
Laboratory Improvement Advisory Committee (CLIAC)

    The Centers for Disease Control and Prevention (CDC) is soliciting 
nominations for membership on CLIAC. CLIAC provides scientific and 
technical advice and guidance to the Secretary, Department of Health 
and Human Services (HHS); the Assistant Secretary for Health, HHS; the 
Director, Centers for Disease Control and Prevention (CDC); the 
Commissioner, Food and Drug Administration (FDA); and the 
Administrator, Centers for Medicare & Medicaid Services (CMS). The 
advice and guidance pertain to general issues related to improvement in 
clinical laboratory quality and laboratory medicine. In addition, the 
Committee provides advice and guidance on specific questions related to 
possible revision of the CLIA standards. Examples include providing 
guidance on studies designed to improve safety, effectiveness, 
efficiency, timeliness, equity, and patient-centeredness of laboratory 
services; revisions to the standards under which clinical laboratories 
are regulated; the impact of proposed revisions to the standards on 
medical and laboratory practice; and the modification of the standards 
and provision of non-regulatory guidelines to accommodate technological 
advances, such as new test methods, the electronic transmission of 
laboratory information, and mechanisms to improve the integration of 
public health and clinical laboratory practices.
    CLIAC consists of 20 members including the Chair, represents a 
diverse membership across laboratory specialties, professional roles 
(laboratory management, technical specialists, physicians, nurses) and 
practice settings (academic, clinical, public health), and includes a 
consumer representative. In addition, the Committee includes three ex 
officio members (or designees), including the Director, CDC; the 
Administrator, CMS; and the Commissioner, FDA. A nonvoting 
representative from the Advanced Medical Technology Association 
(AdvaMed) serves as the industry liaison. The Designated Federal 
Official (DFO) or their designee and the Executive Secretary are 
present at all meetings to ensure meetings are within applicable 
statutory, regulatory and HHS General Administration manual directives.
    Request for Candidates: Nominations are being sought for 
individuals who have expertise and qualifications necessary to 
contribute to accomplishing CLIAC's objectives. Nominees will be 
selected by the HHS Secretary or designee from authorities 
knowledgeable across the fields of microbiology (including 
bacteriology, mycobacteriology, mycology, parasitology, and virology), 
immunology (including histocompatibility), chemistry, hematology, 
pathology (including histopathology and cytology), or genetic testing 
(including cytogenetics); representatives from the fields of medical 
technology, public health, and clinical practice; and consumer 
representatives. Members may be invited to serve for terms of up to 
four years.
    The U.S. Department of Health and Human Services policy stipulates 
that Committee membership be balanced in terms of points of view 
represented, and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens, and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Committee 
members are Special Government Employees, requiring the filing of 
financial disclosure reports at the beginning and annually during their 
terms. CDC reviews potential candidates for CLIAC membership each year, 
and provides a slate of nominees for consideration to the Secretary of 
HHS for final selection. HHS notifies selected candidates of their 
appointment near the start of the term in July, or as soon as the HHS 
selection process is completed. Note that the need for different 
expertise and individuals to maintain the appropriate demographic 
balance varies from year to year and a candidate who is not selected in 
one year may be reconsidered in a subsequent year.
    Candidates should submit the following items to be considered for 
nomination. The deadline for receipt of materials for the 2018 term is 
May 1, 2017:
     Current curriculum vitae, including complete contact 
information (name,

[[Page 12455]]

affiliation, mailing address, telephone number, email address).
     Letter(s) of recommendation from person(s) not employed by 
the U.S. Department of Health and Human Services.
    Contact Person for More Information: Nancy Anderson, Chief, 
Laboratory Practice Standards Branch, Division of Laboratory Systems, 
Center for Surveillance, Epidemiology and Laboratory Services, Office 
of Public Health Scientific Services, Centers for Disease Control and 
Prevention, 1600 Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 
30329-4018; telephone (404) 498-2741; or via email at 
NAnderson@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention, and the Agency for 
Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-04103 Filed 3-2-17; 8:45 am]
 BILLING CODE 4163-18-P

12454 Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices

explained in FTC Rule 4.9(c).11 Your DEPARTMENT OF HEALTH AND HHS General Administration manual
comment will be kept confidential only HUMAN SERVICES directives.
if the FTC General Counsel grants your Request for Candidates: Nominations
request in accordance with the law and Centers for Disease Control and are being sought for individuals who
the public interest. Once your comment Prevention have expertise and qualifications
is posted, as legally required by FTC necessary to contribute to
Rule 4.9(b), we cannot redact or remove Request for Nominations of accomplishing CLIAC’s objectives.
your comment from the FTC’s public Candidates To Serve on the Clinical Nominees will be selected by the HHS
record, including the FTC’s Web site, Laboratory Improvement Advisory Secretary or designee from authorities
unless you submit a confidentiality Committee (CLIAC) knowledgeable across the fields of
request that meets the requirements for The Centers for Disease Control and microbiology (including bacteriology,
such treatment under FTC Rule 4.9(c), Prevention (CDC) is soliciting mycobacteriology, mycology,
and the General Counsel grants that nominations for membership on CLIAC. parasitology, and virology), immunology
request in accordance with the law and (including histocompatibility),
CLIAC provides scientific and technical
the public interest, as explained above. chemistry, hematology, pathology
advice and guidance to the Secretary,
Postal mail addressed to the (including histopathology and cytology),
Department of Health and Human
Commission is subject to delay due to or genetic testing (including
Services (HHS); the Assistant Secretary
heightened security screening. As a cytogenetics); representatives from the
for Health, HHS; the Director, Centers
result, we encourage you to submit your fields of medical technology, public
for Disease Control and Prevention
comments online. To make sure that the health, and clinical practice; and
(CDC); the Commissioner, Food and
Commission considers your online consumer representatives. Members
Drug Administration (FDA); and the
comment, you must file it at https:// may be invited to serve for terms of up
Administrator, Centers for Medicare &
ftcpublic.commentworks.com/ftc/ to four years.
Medicaid Services (CMS). The advice The U.S. Department of Health and
rbprulepra, by following the
instructions on the web-based form. and guidance pertain to general issues Human Services policy stipulates that
When this Notice appears at http:// related to improvement in clinical Committee membership be balanced in
www.regulations.gov/#!home, you also laboratory quality and laboratory terms of points of view represented, and
may file a comment through that Web medicine. In addition, the Committee the committee’s function. Appointments
site. provides advice and guidance on shall be made without discrimination
If you file your comment on paper, specific questions related to possible on the basis of age, race, ethnicity,
write ‘‘RBP Rule, PRA Comment, revision of the CLIA standards. gender, sexual orientation, gender
P145403,’’ on your comment and on the Examples include providing guidance identity, HIV status, disability, and
envelope, and mail or deliver it to the on studies designed to improve safety, cultural, religious, or socioeconomic
following address: Federal Trade effectiveness, efficiency, timeliness, status. Nominees must be U.S. citizens,
Commission, Office of the Secretary, equity, and patient-centeredness of and cannot be full-time employees of
600 Pennsylvania Avenue NW., Suite laboratory services; revisions to the the U.S. Government. Current
CC–5610 (Annex J), Washington, DC standards under which clinical participation on federal workgroups or
20580, or deliver your comment to the laboratories are regulated; the impact of prior experience serving on a federal
following address: Federal Trade proposed revisions to the standards on advisory committee does not disqualify
Commission, Office of the Secretary, medical and laboratory practice; and the a candidate; however, HHS policy is to
Constitution Center, 400 7th Street SW., modification of the standards and avoid excessive individual service on
5th Floor, Suite 5610 (Annex J), provision of non-regulatory guidelines advisory committees and multiple
Washington, DC 20024. If possible, to accommodate technological committee memberships. Committee
submit your paper comment to the advances, such as new test methods, the members are Special Government
Commission by courier or overnight electronic transmission of laboratory Employees, requiring the filing of
service. information, and mechanisms to financial disclosure reports at the
The FTC Act and other laws that the improve the integration of public health beginning and annually during their
Commission administers permit the and clinical laboratory practices. terms. CDC reviews potential candidates
collection of public comments to CLIAC consists of 20 members for CLIAC membership each year, and
consider and use in this proceeding as including the Chair, represents a diverse provides a slate of nominees for
appropriate. The Commission will membership across laboratory consideration to the Secretary of HHS
consider all timely and responsive specialties, professional roles for final selection. HHS notifies selected
public comments that it receives on or (laboratory management, technical candidates of their appointment near
before May 2, 2017. For information on specialists, physicians, nurses) and the start of the term in July, or as soon
the Commission’s privacy policy, practice settings (academic, clinical, as the HHS selection process is
including routine uses permitted by the public health), and includes a consumer completed. Note that the need for
Privacy Act, see http://www.ftc.gov/ftc/ representative. In addition, the different expertise and individuals to
privacy.htm. Committee includes three ex officio maintain the appropriate demographic
members (or designees), including the balance varies from year to year and a
David C. Shonka, Director, CDC; the Administrator, CMS; candidate who is not selected in one
Acting General Counsel. and the Commissioner, FDA. A year may be reconsidered in a
nonvoting representative from the
mstockstill on DSK3G9T082PROD with NOTICES

[FR Doc. 2017–04117 Filed 3–2–17; 8:45 am] subsequent year.
BILLING CODE 6750–01–P Advanced Medical Technology Candidates should submit the
Association (AdvaMed) serves as the following items to be considered for
11 In particular, the written request for industry liaison. The Designated Federal nomination. The deadline for receipt of
confidential treatment that accompanies the Official (DFO) or their designee and the materials for the 2018 term is May 1,
comment must include the factual and legal basis
for the request, and must identify the specific
Executive Secretary are present at all 2017:
portions of the comment to be withheld from the meetings to ensure meetings are within • Current curriculum vitae, including
public record. See FTC Rule 4.9(c), 16 CFR 4.9(c). applicable statutory, regulatory and complete contact information (name,

VerDate Sep<11>2014 16:42 Mar 02, 2017 Jkt 241001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\03MRN1.SGM 03MRN1

Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices 12455

affiliation, mailing address, telephone Management Analysis and Services or verbal communications to the NIOSH
number, email address). Office, CDC, pursuant to Public Law 92– Director during MSHRAC meetings.
• Letter(s) of recommendation from 463. Nominations are being sought for
person(s) not employed by the U.S. Matters for Discussion: The meeting individuals who have expertise and
Department of Health and Human will include the initial review, qualifications necessary to contribute to
Services. discussion, and evaluation of the accomplishment of the committee’s
Contact Person for More Information: applications received in response to mission.
Nancy Anderson, Chief, Laboratory ‘‘Cooperative Research Agreements to Nominees will be selected based on
Practice Standards Branch, Division of the World Trade Center Health Program expertise in the field of mining safety
Laboratory Systems, Center for (U01)’’, PAR 16–098. and health, such as mining engineering,
Surveillance, Epidemiology and Contact Person for More Information: industrial hygiene, occupational safety
Laboratory Services, Office of Public Nina Turner, Ph.D., Scientific Review and health engineering, chemistry,
Health Scientific Services, Centers for Officer, CDC/NIOSH, 1095 Willowdale safety and health education,
Disease Control and Prevention, 1600 Road, Mailstop G905, Morgantown, ergonomics, epidemiology, statistics,
Clifton Road, NE., Mailstop F–11, West Virginia 26505, Telephone: (304) and psychology. Members may be
Atlanta, Georgia 30329–4018; telephone 285–5975. invited to serve for terms of up to four
(404) 498–2741; or via email at The Director, Management Analysis years.
NAnderson@cdc.gov. and Services Office, has been delegated
The Director, Management Analysis The U.S. Department of Health and
the authority to sign Federal Register Human Services policy stipulates that
and Services Office, has been delegated
notices pertaining to announcements of Committee membership be balanced in
the authority to sign Federal Register
meetings and other committee terms of points of view represented, and
notices pertaining to announcements of
management activities, for both the the committee’s function. Appointments
meetings and other committee
Centers for Disease Control and shall be made without discrimination
management activities for both the
Prevention and the Agency for Toxic on the basis of age, race, ethnicity,
Centers for Disease Control and
Substances and Disease Registry. gender, sexual orientation, gender
Prevention, and the Agency for Toxic
Substances and Disease Registry. Elaine L. Baker,
identity, HIV status, disability, and
cultural, religious, or socioeconomic
Director, Management Analysis and Services
Elaine L. Baker, status. Nominees must be U.S. citizens,
Office, Centers for Disease Control and
Director, Management Analysis and Services Prevention. and cannot be full-time employees of
Office, Centers for Disease Control and the U.S. Government. Current
[FR Doc. 2017–04102 Filed 3–2–17; 8:45 am]
Prevention. participation on federal workgroups or
BILLING CODE 4163–18–P
[FR Doc. 2017–04103 Filed 3–2–17; 8:45 am] prior experience serving on a federal
BILLING CODE 4163–18–P advisory committee does not disqualify
DEPARTMENT OF HEALTH AND a candidate; however, HHS policy is to
HUMAN SERVICES avoid excessive individual service on
DEPARTMENT OF HEALTH AND advisory committees and multiple
HUMAN SERVICES Centers for Disease Control and committee memberships. Committee
Prevention members are Special Government
Centers for Disease Control and Employees, requiring the filing of
Prevention Request for Nominations of financial disclosure reports at the
Candidates To Serve on the Mine beginning and annually during their
Disease, Disability, and Injury
Safety and Health Research Advisory terms. CDC reviews potential candidates
Prevention and Control Special
Committee (MSHRAC), National for the MSHRAC membership each year,
Emphasis Panel (SEP): Initial Review
Institute for Occupational Safety and and provides a slate of nominees for
In accordance with Section 10(a)(2) of Health, Centers for Disease Control consideration to the Secretary of HHS
the Federal Advisory Committee Act and Prevention (CDC), Department of for final selection.
(Pub. L. 92–463), the Centers for Disease Health and Human Services Candidates should submit the
Control and Prevention (CDC) following items:
announces a meeting for the initial The CDC is soliciting nominations for
possible membership on the Mine • Current curriculum vitae, including
review of applications in response to complete contact information (name,
Funding Opportunity Announcement Safety and Health Research Advisory
Committee (MSHRAC), National affiliation, mailing address, telephone
(FOA), PAR 16–098 Cooperative number, email address)
Research Agreements to the World Institute for Occupational Safety and
Health (NIOSH). • A letter of recommendation stating
Trade Center Health Program (U01).
The MSHRAC consists of 13 experts the qualifications of the candidate.
Times and Dates:
8:00 a.m.–5:00 p.m., EDT, March 28, in fields related to mining safety and Nomination materials must be
2017 (Closed) health. The members are selected by the postmarked by April 30, 2017, and sent
8:00 a.m.–12:00 p.m., EDT, March 29, Secretary of the U.S. Department of to: Jeffrey H. Welsh, Designated Federal
2017(Closed) Health and Human Services (HHS). The Officer for MSHRAC, NIOSH, CDC, 626
Place: Courtyard Marriott Decatur committee advises the NIOSH Director Cochrans Mill Road, Pittsburgh, PA
Downtown/Emory, 130 Clairemont on mining safety and health research 15236, telephone (412) 386–4040.
mstockstill on DSK3G9T082PROD with NOTICES

Avenue, Decatur, Georgia 30030, and prevention programs. The The Director, Management Analysis
Telephone: (404)371–0204. committee also provides advice on and Services Office, has been delegated
Status: The meeting will be closed to standards of scientific excellence, the authority to sign Federal Register
the public in accordance with current needs in the field of mining Notices pertaining to announcements of
provisions set forth in Section 552b(c) safety and health, and the applicability meetings and other committee
(4) and (6), Title 5 U.S.C., and the and dissemination of research findings. management activities, for the Centers
Determination of the Director, This advice may take the form of reports for Disease Control and Prevention and

VerDate Sep<11>2014 16:42 Mar 02, 2017 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\03MRN1.SGM 03MRN1

Document Created: 2018-02-01 14:45:48
Document Modified: 2018-02-01 14:45:48

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to accomplishing CLIAC's objectives. Nominees will be selected by the HHS Secretary or designee from authorities knowledgeable across the fields of microbiology (including bacteriology, mycobacteriology, mycology, parasitology, and virology), immunology (including histocompatibility), chemistry, hematology, pathology (including histopathology and cytology), or genetic testing (including cytogenetics); representatives from the fields of medical technology, public health, and clinical practice; and consumer representatives. Members may be invited to serve for terms of up to four years.
FR Citation		82 FR 12454

82 FR 12454 - Request for Nominations of Candidates To Serve on the Clinical Laboratory Improvement Advisory Committee (CLIAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 82, Issue 41 (March 3, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention